- Home
- FFIV vs ASND Comparison
FFIV vs ASND Comparison
Compare FFIV & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FFIV | ASND |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 13.6B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FFIV | ASND |
|---|---|---|
| Price | $287.11 | $239.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $305.50 | $278.80 |
| AVG Volume (30 Days) | 566.6K | ★ 758.7K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.56 | N/A |
| EPS | ★ 3.10 | N/A |
| Revenue | ★ $3,088,072,000.00 | N/A |
| Revenue This Year | $8.00 | $98.02 |
| Revenue Next Year | $3.27 | $43.13 |
| P/E Ratio | $91.89 | ★ N/A |
| Revenue Growth | ★ 9.66 | N/A |
| 52 Week Low | $223.76 | $124.06 |
| 52 Week High | $346.00 | $248.60 |
Technical Indicators
Market Signals| Indicator | FFIV | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 58.82 |
| Support Level | $284.47 | $190.49 |
| Resistance Level | $303.03 | $242.00 |
| Average True Range (ATR) | 8.52 | 9.53 |
| MACD | 0.78 | 0.74 |
| Stochastic Oscillator | 89.22 | 67.87 |
Price Performance
Historical ComparisonAbout FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.